Equities

Sofwave Medical Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
SOFW:TLV

Sofwave Medical Ltd

Actions
Health CareMedical Equipment and Services
  • Price (ILa)3,550.00
  • Today's Change-79.00 / -2.18%
  • Shares traded35.18k
  • 1 Year change+104.38%
  • Beta1.4841
Data delayed at least 20 minutes, as of Feb 17 2026 15:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Sofwave Medical Ltd, formerly known as Archimedus Medical Ltd, is an Israel-based medical device manufacturer and medical software publisher. The Company operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The Company has subsidiary in United States -Sofwave Medical Inc.

  • Revenue in ILS (TTM)237.60m
  • Net income in ILS2.11m
  • Incorporated2015
  • Employees126.00
  • Location
    Sofwave Medical LtdHa-Otsma 1YOKNEAM 2069500IsraelISR
  • Fax+972 732017658
  • Websitehttps://sofwave.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Epitomee Medical Ltd0.001.01m259.99m42.00252.462.7282.18--0.03420.03420.003.180.00----0.000.9033-18.000.9604-18.81-------372.227.65--0.1275---100.00--74.23--107.15--
Ilex Medical Ltd906.61m50.36m650.81m176.0012.940.9666.480.71794.503.8980.9160.220.91684.063.705,151,216.005.0912.096.9617.2422.9229.665.5511.172.08--0.067832.690.45017.74-17.69-5.381.29--
Sofwave Medical Ltd237.60m2.11m1.30bn126.001,075.2114.83167.145.470.03350.03356.382.431.783.548.121,885,719.001.58--2.53--75.56--0.8877--2.082.010.0463--18.56--45.08------
Brainsway Ltd151.39m19.27m1.44bn120.0079.606.4657.399.520.46160.46163.485.680.53033.0411.351,261,552.006.75-8.728.53-10.2274.9275.2612.73-17.453.02--0.0879--29.0412.17169.60--2.76--
Vicenne337.47m43.22m1.55bn--35.846.5031.004.5912.4512.4597.1668.63----------------40.66--12.81--1.9271.140.2609--19.57--55.53------
Data as of Feb 17 2026. Currency figures normalised to Sofwave Medical Ltd's reporting currency: Israeli Shekel ILS

Institutional shareholders

23.43%Per cent of shares held by top holders
HolderShares% Held
Phoenix Provident Fund Ltd.as of 31 Mar 20254.04m11.21%
Migdal Makefet Pension & Provident Funds Ltd.as of 07 Aug 20253.09m8.59%
Yelin Lapidot Mutual Fund Management Ltd.as of 30 Nov 2025700.29k1.95%
Harel Mutual Funds Ltd.as of 30 Nov 2025299.95k0.83%
Meitav Mutual Funds Ltd.as of 30 Nov 2025172.71k0.48%
Psagot Mutual Funds Ltd.as of 30 Nov 202541.12k0.11%
KSM Mutual Funds Ltd.as of 30 Nov 202540.35k0.11%
Migdal Mutual Funds Ltd.as of 07 Aug 202521.38k0.06%
Ayalon Mutual Funds Ltd.as of 27 Nov 202520.96k0.06%
WCM Investment Management LLCas of 31 Jan 20269.98k0.03%
More ▼
Data from 30 Nov 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.